Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

t-cell   symbols : Grcl    save search

Gracell Biotechnologies Presents Longer-Term Results for FasTCAR-T GC012F in B-Cell Non-Hodgkin’s Lymphoma at EHA2023, Highlighting 100% Overall Response Rate
Published: 2023-06-10 (Crawled : 16:20) - globenewswire.com
GRCL | $10.25 -0.29% 6.4M twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

gc012 response results
Gracell Biotechnologies' Abstract on GC012F, a BCMA/CD19 Dual-targeting CAR-T Cell Therapy, Accepted for Presentation at 2022 ASCO Annual Meeting
Published: 2022-04-14 (Crawled : 13:00) - biospace.com/
GRCL | $10.25 -0.29% 6.4M twitter stocktwits trandingview |
Manufacturing
| | O: -0.92% H: 2.78% C: -4.63%

gc012 car-t presentation asco
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin's Lymphoma
Published: 2022-02-17 (Crawled : 14:00) - biospace.com/
GRCL | $10.25 -0.29% 6.4M twitter stocktwits trandingview |
Manufacturing
| | O: 0.53% H: 2.65% C: -5.82%

gc012 car-t trial cel therapy biotech iot t-cell
Gracell Biotechnologies Granted FDA Orphan Drug Designation for FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy Candidate GC012F for the Treatment of Multiple Myeloma
Published: 2021-11-19 (Crawled : 12:00) - biospace.com/
GRCL | $10.25 -0.29% 6.4M twitter stocktwits trandingview |
Manufacturing
| | O: 21.78% H: 4.25% C: -19.25%

gc012 treatment fda orphan drug therapy car-t biotech drug iot granted t-cell designation
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
GRCL | $10.25 -0.29% 6.4M twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

therapy car-t results biotech iot preclinical t-cell pre-clinical
Gainers vs Losers
72% 28%

Top 10 Gainers
CZOO | $9.98 100.0% 330K twitter stocktwits trandingview |

AMST | $3.48 74.0% 21M twitter stocktwits trandingview |
Technology Services

CSSE 4 | $0.2184 43.4% 36M twitter stocktwits trandingview |
Consumer Services

BW | News | $1.0002 9.05% 190K twitter stocktwits trandingview |
Electronic Technology

DXYZ 4 | $30.91 8.49% 73K twitter stocktwits trandingview |
n/a

CSGP | News | $90.34 6.76% 180K twitter stocktwits trandingview |
Technology Services

BSX | $73.35 6.32% 1M twitter stocktwits trandingview |
Health Technology

ZLAB | $16.07 6.28% 28K twitter stocktwits trandingview |
Health Technology

ALGM | $28.08 5.68% 86K twitter stocktwits trandingview |
Electronic Technology

ALLK | $1.1 4.76% 23K twitter stocktwits trandingview |
Health Technology


Your saved searches
Save your searches and get alerts when important news are released.